News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
69,538 Results
Type
Article (1938)
Company Profile (2)
Press Release (67598)
Section
Business (21541)
Career Advice (9)
Deals (4566)
Drug Delivery (1)
Drug Development (8172)
FDA (1809)
Job Trends (803)
News (37136)
Policy (3585)
Tag
Academia (91)
Alliances (8141)
Alzheimer's disease (119)
Antibody-drug conjugate (ADC) (8)
Approvals (1824)
Artificial intelligence (10)
Bankruptcy (8)
Best Places to Work (585)
Biosimilars (14)
Breast cancer (15)
Cancer (160)
Career advice (9)
Cell therapy (16)
Clinical research (6941)
Collaboration (64)
COVID-19 (186)
C-suite (9)
Data (139)
Diabetes (12)
Diagnostics (592)
Drug discovery (12)
Duchenne muscular dystrophy (7)
Earnings (7537)
Events (6906)
Executive appointments (40)
FDA (1903)
Funding (41)
Gene therapy (14)
GLP-1 (43)
Government (238)
Healthcare (1074)
Infectious disease (190)
Inflammatory bowel disease (14)
Intellectual property (8)
IPO (1625)
Job creations (242)
Job search strategy (9)
Layoffs (6)
Legal (950)
Liver cancer (15)
Lung cancer (27)
Lymphoma (9)
Manufacturing (26)
Medical device (1115)
Medtech (1116)
Mergers & acquisitions (3007)
Metabolic disorders (33)
Neuroscience (151)
NextGen: Class of 2025 (221)
Non-profit (62)
Northern California (109)
Obesity (15)
Ovarian cancer (7)
Pancreatic cancer (6)
Parkinson's disease (12)
Patents (12)
People (4955)
Phase I (1886)
Phase II (2899)
Phase III (2638)
Pipeline (60)
Postmarket research (242)
Preclinical (655)
Radiopharmaceuticals (22)
Rare diseases (21)
Real estate (599)
Regulatory (2565)
Research institute (91)
Schizophrenia (6)
Series A (11)
Southern California (102)
Startups (421)
United States (958)
Vaccines (20)
Date
Last 7 days (57)
Last 30 days (207)
Last 365 days (3202)
2025 (214)
2024 (3259)
2023 (3822)
2022 (7042)
2021 (6414)
2020 (5934)
2019 (3888)
2018 (3014)
2017 (3569)
2016 (3185)
2015 (4046)
2014 (3025)
2013 (2604)
2012 (2784)
2011 (2904)
2010 (2663)
Location
Africa (83)
Arizona (7)
Asia (21276)
Australia (2423)
California (247)
Canada (184)
China (120)
Connecticut (11)
Europe (12340)
Florida (15)
Illinois (16)
India (9)
Japan (55)
Maryland (66)
Massachusetts (175)
Minnesota (24)
New Jersey (135)
New York (112)
North Carolina (50)
Northern California (109)
Pennsylvania (35)
South America (105)
Southern California (102)
Texas (17)
Utah (8)
Virginia (14)
69,538 Results for "cipla ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Exelixis Announces Settlement of CABOMETYX® (cabozantinib) Patent Litigation with Cipla Limited and Cipla USA
Exelixis, Inc. (Nasdaq: EXEL) today announced that it has entered into a Settlement and License Agreement (Agreement) with Cipla Ltd. and Cipla USA, Inc. (collectively Cipla).
May 20, 2024
·
3 min read
Business
Pulmatrix Announces Stopping the PUR1900 Phase 2B Study Patient Enrollment and Closing the Study, in Agreement With Partner Cipla, to Preserve Cash and Facilitate Pursuit of Strategic Alternatives
Pulmatrix today announced that it has entered into a further amendment to its agreement with Cipla for the development of PUR1900 in the treatment of Allergic Bronchopulmonary Aspergillosis (ABPA).
January 8, 2024
·
6 min read
Policy
Cipla Issues Voluntary Nationwide Recall of Six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) due to Container Defect
Cipla Limited, announced that its wholly-owned subsidiary Cipla US is voluntarily recalling six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg manufactured in November 2021 to the consumer level.
July 6, 2023
·
3 min read
Press Releases
BlackfinBio Ltd announces the acquisition of Parkinson’s IP patent portfolio from OXB
January 8, 2025
·
1 min read
Press Releases
WORK Medical Technology Group LTD’s Subsidiary, Hangzhou Shanyou, Showcases Products at MEDICA Trade Fair 2024
November 28, 2024
·
4 min read
Press Releases
AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.
December 24, 2024
·
8 min read
Press Releases
AI/ML Innovations to Acquire Quantum Sciences Ltd
December 10, 2024
·
4 min read
Press Releases
Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc.
January 24, 2025
·
5 min read
Press Releases
Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd
December 18, 2024
·
4 min read
Pharm Country
Cipla Announces Launch of Leuprolide Acetate Injection Depot (22.5mg)
Cipla Limited and its wholly owned subsidiary Cipla USA Inc., announced the launch of Leuprolide Acetate Injection Depot 22.5mg.
November 29, 2022
·
2 min read
1 of 6,954
Next
